Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-02

Clinical Trial Update: Bariatric Surgery vs. Semaglutide vs. Tirzepatide [Phase 4]

View source ↗

Summary

This Phase 4 trial is investigating obesity management by comparing bariatric surgery with semaglutide and tirzepatide. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bariatric Surgery
  • Tirzepatide (tirzepatide)
  • semaglutide (semaglutide)

Snippet

Sponsor: Ali Aminian | Conditions: Obesity and Obesity-related Medical Conditions | Phase 4 | Status: RECRUITING